Management of CRSwNP in Latin America: A multidisciplinary consensus from an expert working group
- PMID: 38463018
- PMCID: PMC10924205
- DOI: 10.1016/j.waojou.2024.100886
Management of CRSwNP in Latin America: A multidisciplinary consensus from an expert working group
Abstract
Chronic rhinosinusitis with nasal polyps (CRSwNP) is an inflammatory condition of the nasal and paranasal tissues, characterized by the presence of bilateral nasal polyps. While etiology and pathogenetic mechanisms are heterogeneous and complex, in most patients, disease is mediated predominantly through type 2 inflammatory processes. Clinical management is challenging, and a multidisciplinary approach is preferred. Principal treatment approaches are the use of local/systemic corticosteroids and sinonasal surgery, although outcomes can be unsatisfactory. Recent availability of biological therapies targeting underlying inflammatory processes can offer effective treatment options in uncontrolled disease. Specialist guidelines greatly assist clinical decision-making, although as these are chiefly written from a global/international perspective, they may not wholly accommodate disease patterns and clinical practice at a regional level. An expert panel of specialists from Latin America was convened to develop regional guidance on the management of CRSwNP through a consensus approach. The present article presents the chief observations and recommendations which can provide guidance for clinicians in the Latin American region.
Keywords: Biologics; CRSwNP; Chronic rhinosinusitis with nasal polyposis; Type 2 inflammation.
© 2024 Published by Elsevier Inc. on behalf of World Allergy Organization.
Conflict of interest statement
JFM has acted as a speaker, advisory board member, and/or investigator for Sanofi, AstraZeneca, Novartis, Inmunito, Uriach, GSK, Menarini and MSD. DB has attended advisory board and received sponsorship from Sanofi. AS has acted as an advisor for Sanofi. WA-L, MAJC, JO, RR and RSR have no direct or indirect conflict of interests to declare.
Figures


Similar articles
-
Management of chronic rhinosinusitis with nasal polyps in the Asia-Pacific region and Russia: Recommendations from an expert working group.Asia Pac Allergy. 2024 Jun;14(2):77-83. doi: 10.5415/apallergy.0000000000000139. Epub 2024 Apr 4. Asia Pac Allergy. 2024. PMID: 38827258 Free PMC article. Review.
-
Management of Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) in the Pan-Arab Region: Consensus Recommendations from a Multidisciplinary Expert Working Group.J Asthma Allergy. 2023 Sep 29;16:1055-1063. doi: 10.2147/JAA.S413610. eCollection 2023. J Asthma Allergy. 2023. PMID: 37795191 Free PMC article.
-
Biologics for severe uncontrolled chronic rhinosinusitis with nasal polyps: a change management approach. Consensus of the Joint Committee of Italian Society of Otorhinolaryngology on biologics in rhinology.Acta Otorhinolaryngol Ital. 2022 Feb;42(1):1-16. doi: 10.14639/0392-100X-N1614. Epub 2021 Jul 23. Acta Otorhinolaryngol Ital. 2022. PMID: 34297014 Free PMC article. Review.
-
Personalized Management of Patients with Chronic Rhinosinusitis with Nasal Polyps in Clinical Practice: A Multidisciplinary Consensus Statement.J Pers Med. 2022 May 23;12(5):846. doi: 10.3390/jpm12050846. J Pers Med. 2022. PMID: 35629268 Free PMC article. Review.
-
Expert Opinion on Biological Treatment of Chronic Rhinosinusitis with Nasal Polyps in the Gulf Region.J Asthma Allergy. 2022 Jan 4;15:1-12. doi: 10.2147/JAA.S321017. eCollection 2022. J Asthma Allergy. 2022. PMID: 35018101 Free PMC article. Review.
Cited by
-
Combined corticosteroid therapy enhances outcomes of endoscopic sinus surgery in chronic rhinosinusitis with nasal polyps: a prospective cohort study.Am J Transl Res. 2025 Jul 15;17(7):5173-5185. doi: 10.62347/XYEC4626. eCollection 2025. Am J Transl Res. 2025. PMID: 40821092 Free PMC article.
References
Publication types
LinkOut - more resources
Full Text Sources